Procalcitonin for the clinical laboratory: a review

References

• Becker K. L., Nylen E. S., White J. C., Muller B., Snider R. H Jr. procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89: 1512–25
   PubMed Web of Science ®Google Scholar
• Muller B., Becker K. L. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 2001; 131: 595–602
   PubMed Web of Science ®Google Scholar
• Muller B., White J. C., Nylen E. S., Snider R. H., Becker K. L., Habener J. F. Ubiquitous expression of the calcitonin‐i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001; 86: 396–404
   PubMed Web of Science ®Google Scholar
• Linscheid P., Seboek D., Nylen E. S., et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003; 144: 5578–84
   PubMed Web of Science ®Google Scholar
• Mitaka C. Clinical laboratory differentiation of infectious versus non‐infectious systemic inflammatory response syndrome. Clin Chim Acta 2005; 351: 17–29
   PubMed Web of Science ®Google Scholar
• Whang K. T., Steinwald P. M., White J. C., et al. Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 1998; 83: 3296–301
   PubMed Web of Science ®Google Scholar
• Dandona P., Nix D., Wilson M. F., et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605–8
   PubMed Web of Science ®Google Scholar
• Gabay C., Kushner I. Acute‐phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–54
   PubMed Web of Science ®Google Scholar
• Delevaux I., Andre M., Colombier M., et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?. Ann Rheum Dis 2003; 62: 337–40
   PubMed Web of Science ®Google Scholar
• Wanner G. A., Keel M., Steckholzer U., Beier W., Stocker R., Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000; 28: 950–7
   PubMed Web of Science ®Google Scholar
• Christ‐Crain M., Jaccard‐Stolz D., Bingisser R., et al. Effect of procalcitonin‐guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster‐randomised, single‐blinded intervention trial. Lancet 2004; 363: 600–7
   PubMed Web of Science ®Google Scholar
• Christ‐Crain M., Muller B. Procalcitonin in bacterial infections—hype, hope, more or less?. Swiss Med Wkly 2005; 135: 451–60
   PubMed Web of Science ®Google Scholar
• Nylen E. S., Whang K. T., Snider R. H Jr., Steinwald P. M., White J. C., Becker K. L. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26: 1001–6
   PubMed Web of Science ®Google Scholar
• Fernandez Lopez A., Luaces Cubells C., Garcia Garcia J. J., Fernandez Pou J. Spanish Society of Pediatric Emergencies. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 2003; 22: 895–903
   PubMed Web of Science ®Google Scholar
• Morgenthaler N. G., Struck J., Fischer‐Schulz C., Seidel‐Mueller E., Beier W., Bergmann A. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clin Lab 2002; 48: 263–70
   PubMedGoogle Scholar
• Barassi A., Pallotti F., Melzi d'Eril G. Biological variation of procalcitonin in healthy individuals. Clin Chem 2004; 50: 1878
   PubMed Web of Science ®Google Scholar
• Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864–74
   PubMed Web of Science ®Google Scholar
• Levy M. M., Fink M. P., Marshall J. C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250–6
   PubMed Web of Science ®Google Scholar
• Al‐Nawas B., Krammer I., Shah P. M. Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996; 1: 331–3
   PubMedGoogle Scholar
• Ugarte H., Silva E., Mercan D., De Mendonca A., Vincent J. L. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498–504
   PubMed Web of Science ®Google Scholar
• Brunkhorst F. M., Eberhard O. K., Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999; 27: 2172–6
   PubMed Web of Science ®Google Scholar
• Brunkhorst F. M., Wegscheider K., Forychi Z. F., Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000; 26: S148–52
   PubMed Web of Science ®Google Scholar
• Suprin E., Camus C., Gacouin A., Le Tulzo Y., Lavoue S., Feuillu A., Thomas R. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 2000; 26: 1232–8
   PubMed Web of Science ®Google Scholar
• Muller B., Becker K. L., Schachinger H., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28: 977–83
   PubMed Web of Science ®Google Scholar
• Selberg O., Hecker H., Martin M., Klos A., Bautsch W., Kohl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin‐6. Crit Care Med 2000; 28: 2793–8
   PubMed Web of Science ®Google Scholar
• Harbarth S., Holeckova K., Froidevaux C., et al. and the Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin‐6, and interleukin‐8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396–402
   PubMed Web of Science ®Google Scholar
• Liaudat S., Dayer E., Praz G., Bille J., Troillet N. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001; 20: 524–7
   PubMed Web of Science ®Google Scholar
• Giamarellos‐Bourboulis E. J., Mega A., Grecka P., et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?. Intensive Care Med 2002; 28: 1351–6
   PubMed Web of Science ®Google Scholar
• Ruokonen E., Ilkka L., Niskanen M., Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 2002; 46: 398–404
   PubMed Web of Science ®Google Scholar
• Tugrul S., Esen F., Celebi S., et al. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care 2002; 30: 747–54
   PubMed Web of Science ®Google Scholar
• Bell K., Wattie M., Byth K., et al. Procalcitonin: A marker of bacteraemia in SIRS. Anaesth Intensive Care 2003; 31: 629–36
   PubMed Web of Science ®Google Scholar
• Balci C., Sungurtekin H., Gürses E., Sungurtekin U., Kaptanoğlu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003; 7: 85–90
   PubMed Web of Science ®Google Scholar
• Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., Merlini A. Comparison of procalcitonin and C‐reactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737–41
   PubMed Web of Science ®Google Scholar
• Du B., Pan J., Chen D., Li Y. Serum procalcitonin and interleukin‐6 levels may help to differentiate systemic inflammatory response of infectious and non‐infectious origin. Chin Med J (Engl) 2003; 116: 538–42
   PubMed Web of Science ®Google Scholar
• Castelli G. P., Pognani C., Meisner M., Stuani A., Bellomi D., Sgarbi L. Procalcitonin and C‐reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004; 8: R234–42
   PubMed Web of Science ®Google Scholar
• Clec'h C., Ferriere F., Karoubi P., et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004; 32: 1166–9
   PubMed Web of Science ®Google Scholar
• Giamarellou H., Giamarellos‐Bourboulis E. J., Repoussis P., et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect 2004; 10: 628–33
   PubMed Web of Science ®Google Scholar
• Boussekey N., Leroy O., Georges H., Devos P., d'Escrivan T., Guery B. Diagnostic and prognostic values of admission procalcitonin levels in community‐acquired pneumonia in an intensive care unit. Infection 2005; 33: 257–63
   PubMed Web of Science ®Google Scholar
• Simon L., Gauvin F., Amre D. K., Saint‐Louis P., Lacroix J. Serum procalcitonin and C‐reactive protein levels as markers of bacterial infection: a systematic review and meta‐analysis. Clin Infect Dis 2004; 39: 206–17
   PubMed Web of Science ®Google Scholar
• Uzzan B., Cohen R., Nicolas P., Cucherat M., Perret G. Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta‐analysis. Crit Care Med 2006; 34: 1996–2003
   PubMed Web of Science ®Google Scholar
• Hatherill M., Tibby S. M., Sykes K., Turner C., Murdoch I. A. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 1999; 81: 417–21
   PubMed Web of Science ®Google Scholar
• Galetto‐Lacour A., Zamora S. A., Gervaix A. Bedside procalcitonin and C‐reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003; 112: 1054–60
   PubMed Web of Science ®Google Scholar
• Carrol E. D., Newland P., Riordan F. A., Thomson A. P., Curtis N., Hart C. A. Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child 2002; 86: 282–5
   PubMed Web of Science ®Google Scholar
• Matesanz J. L., Fernandez E., Fernandez J. M., Viejo G. Plasma procalcitonin and C‐reactive protein concentrations in pediatric patients with Epstein‐Barr virus infection. Clin Chem 2003; 49: 2103–4
   PubMed Web of Science ®Google Scholar
• Sachse C., Dressler F., Henkel E. Increased serum procalcitonin in newborn infants without infection. Clin Chem 1998; 44: 1343–4
   PubMed Web of Science ®Google Scholar
• Martin‐Denavit T., Monneret G., Labaune J. M., et al. Usefulness of procalcitonin in neonates at risk for infection. Clin Chem 1999; 45: 440–1
   PubMed Web of Science ®Google Scholar
• Chiesa C., Pellegrini G., Panero A., et al. C‐reactive protein, interleukin‐6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003; 49: 60–8
   PubMed Web of Science ®Google Scholar
• Elsammak M., Hanna H., Ghazal A., Edeen F. B., Kandil M. Diagnostic value of serum procalcitonin and C‐reactive protein in Egyptian children with streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2006; 25: 174–6
   PubMed Web of Science ®Google Scholar
• Moulin F., Raymond J., Lorrot M., et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001; 84: 332–6
   PubMed Web of Science ®Google Scholar
• Korppi M., Remes S. Serum procalcitonin in pneumococcal pneumonia in children. Eur Respir J 2001; 17: 623–7
   PubMed Web of Science ®Google Scholar
• Gurgoze M. K., Akarsu S., Yilmaz E., et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol 2005; 20: 1445–8
   PubMed Web of Science ®Google Scholar
• Pecile P., Miorin E., Romanello C., et al. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics 2004; 114: e249–54
   PubMed Web of Science ®Google Scholar
• Benador N., Siegrist C. A., Gendrel D., et al. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 1998; 102: 1422–5
   PubMed Web of Science ®Google Scholar
• Leclerc F., Leteurtre S., Noizet O., et al. Procalcitonin as a prognostic marker in children with meningococcal septic shock. Arch Dis Child 2002; 87: 450
   PubMed Web of Science ®Google Scholar
• Marc E., Menager C., Moulin F., et al. Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak. (French.). Arch Pediatr 2002; 9: 358–64
   PubMed Web of Science ®Google Scholar
• Giamarellos‐Bourboulis E. J., Grecka P., Poulakou G., Anargyrou K., Katsilambros N., Giamarellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 2001; 32: 1718–25
   PubMed Web of Science ®Google Scholar
• Pihusch M., Pihusch R., Fraunberger P., et al. Evaluation of C‐reactive protein, interleukin‐6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol 2006; 76: 93–101
   PubMed Web of Science ®Google Scholar
• Hambach L., Eder M., Dammann E., et al. Diagnostic value of procalcitonin serum levels in comparison with C‐reactive protein in allogeneic stem cell transplantation. Haematologica 2002; 87: 643–51
   PubMed Web of Science ®Google Scholar
• Blijlevens N. M., Donnelly J. P., Meis J. F., De Keizer M. H., De Pauw B. E. Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 2000; 7: 889–92
   PubMedGoogle Scholar
• Ortega M., Rovira M., Filella X., et al. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br J Haematol 2004; 126: 372–6
   PubMed Web of Science ®Google Scholar
• Lam Q. T., Au P., Schwarer A., Schneider H. G. Measurement of procalcitonin in the investigation of fever in the bone marrow transplant population. Clin Biochem Rev 2002; 23, Abstr 77
   Google Scholar
• Shafiq N., Malhotra S., Bhasin D. K., Rana S., Siddhu S., Pandhi P. Estimating the diagnostic accuracy of procalcitonin as a marker of the severity of acute pancreatitis: a meta‐analytic approach. J Pancreas 2005; 6: 231–7
   PubMedGoogle Scholar
• Modrau I. S., Floyd A. K., Thorlacius‐Ussing O. The clinical value of procalcitonin in early assessment of acute pancreatitis. Am J Gastroenterol 2005; 100: 1593–7
   PubMed Web of Science ®Google Scholar
• Melzi D'Eril G. V., Merlini G., Finazzi S., Bosoni T., Barakat B., Pezzilli R. Procalcitonin is not a reliable marker for the assessment of severity in acute pancreatitis without infectious complications. Clin Chem 2000; 46: 428–30
   PubMed Web of Science ®Google Scholar
• Brunkhorst F. M., Eberhard O. K., Brunkhorst R. Early identification of biliary pancreatitis with procalcitonin. Am J Gastroenterol 1998; 93: 1191–2
   PubMed Web of Science ®Google Scholar
• Müller C. A., Uhl W., Printzen G., et al. Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut 2000; 46: 233–8
   PubMed Web of Science ®Google Scholar
• Rau B., Steinbach G., Gansauge F., Mayer J. M., Grunert A., Beger H. G. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41: 832–40
   PubMed Web of Science ®Google Scholar
• Bihari D. Monitoring procalcitonin is of value in acute pancreatitis. BMJ 2004; 329: 232
   PubMed Web of Science ®Google Scholar
• Herget‐Rosenthal S., Marggraf G., Pietruck F., et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 2001; 16: 975–9
   PubMed Web of Science ®Google Scholar
• Level C., Chauveau P., Delmas Y., et al. Procalcitonin: a new marker of inflammation in haemodialysis patients?. Nephrol Dial Transplant 2001; 16: 980–6
   PubMed Web of Science ®Google Scholar
• Madhi S. A., Heera J. R., Kuwanda L., Klugman K. P. Use of procalcitonin and C‐reactive protein to evaluate vaccine efficacy against pneumonia. PLoS Med 2005; 2: e38
   PubMed Web of Science ®Google Scholar
• Mueller C., Huber P., Laifer G., Mueller B., Perruchoud A. P. Procalcitonin and the early diagnosis of infective endocarditis. Circulation 2004; 109: 1707–10
   PubMed Web of Science ®Google Scholar
• Polzin A., Pletz M., Erbes R., et al. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 2003; 21: 939–43
   PubMed Web of Science ®Google Scholar
• Hollenstein U., Looareesuwan S., Aichelburg A., et al. Serum procalcitonin levels in severe Plasmodium falciparum malaria. Am J Trop Med Hyg 1998; 59: 860–3
   PubMed Web of Science ®Google Scholar
• Wagner F. D., Jonitz B., Potapov E. V., et al. Procalcitonin, a donor‐specific predictor of early graft failure‐related mortality after heart transplantation. Circulation 2001; 104((Suppl 1))I192–6
   PubMed Web of Science ®Google Scholar
• Christ‐Crain M., Stolz D., Bingisser R., et al. Procalcitonin guidance of antibiotic therapy in community‐acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006; 174: 84–93
   PubMed Web of Science ®Google Scholar
• el Moussaoui R., de Borgie C. A., van den Broek P., et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate‐severe community acquired pneumonia: randomised, double blind study. BMJ 2006; 332: 1355
   PubMed Web of Science ®Google Scholar
• Chromik A. M., Endter F., Uhl W., Thiede A., Reith H. B., Mittelkotter U. Pre‐emptive antibiotic treatment vs ‘standard’ treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study. Langenbecks Arch Surg 2006; 391: 87–94
   Web of Science ®Google Scholar